| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-13 17:03:56 -0600 |
| HMDB ID |
HMDB00262 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Thymine |
| Description |
One of the pyrimidine bases of living matter. Derivation: Hydrolysis of deoxyribonucleic acid, from methylcyanoacetylurea by catalytic reduction. Use: Biochemical research. (Hawley's Condensed Chemical Dictionary). Thymine is a pyrimidine nucleobase. As the name implies, thymine may be derived by methylation of uracil at the 5th carbon. Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2,4-Dihydroxy-5-methylpyrimidine
- 4-Hydroxy-5-methylpyrimidin-2(1H)-one
- 5-Methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 5-Methyl-2,4(1H,3H)-pyrimidinedione
- 5-Methyl-2,4-dihydroxypyrimidine
- 5-Methylpyrimidine-2,4-dione
- 5-Methyluracil
- Thymine
|
| Chemical Formula |
C5H6N2O2 |
| Average Molecular Weight |
126.1133 |
| Monoisotopic Molecular Weight |
126.042927446 |
| IUPAC Name |
5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione |
| Traditional IUPAC Name |
thymine |
| CAS Registry Number |
65-71-4 |
| SMILES |
CC1=CNC(=O)NC1=O |
| InChI Identifier |
InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9) |
| InChI Key |
RWQNBRDOKXIBIV-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Heteromonocyclic Compounds |
| Class |
Diazines |
| Sub Class |
Pyrimidines and Pyrimidine Derivatives |
| Other Descriptors |
- Pyrimidines and Pyrimidine Derivatives
- Pyrimidines(KEGG)
- a pyrimidine base(Cyc)
- a pyrimidine-related compound(Cyc)
- pyrimidine nucleobase(ChEBI)
- pyrimidone(ChEBI)
|
| Substituents |
|
| Direct Parent |
Pyrimidones |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Purine metabolism
- Component of Pyrimidine metabolism
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
320 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
3.82 mg/mL |
YALKOWSKY,SH & DANNENFELSER,RM (1992) |
| LogP |
-0.62 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum EI-B (HITACHI M-80) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Fibroblasts
- Prostate
- Skin
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
<5.0 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0 - 0.1 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.10 (0.045-0.16) umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.16 (0.065-0.26) umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.202 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
1390.0 +/- 150.0 uM |
Adult (>18 years old) |
Both |
Thymidine treatment |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.04 - 0.2 uM |
Adult (>18 years old) |
Not Specified |
Beta-ureidopropionase deficiency |
Not Available |
| Urine |
Detected and Quantified |
|
1.0 (0.00-2.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Dihydropyrimidine dehydrogenase deficiency |
Not Available |
| Urine |
Detected and Quantified |
|
50.0 (20.0-80.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Dihydropyrimidine dehydrogenase deficiency |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Beta-ureidopropionase deficiency |
- van Kuilenburg AB, Meinsma R, Beke E, Assmann B, Ribes A, Lorente I, Busch R, Mayatepek E, Abeling NG, van Cruchten A, Stroomer AE, van Lenthe H, Zoetekouw L, Kulik W, Hoffmann GF, Voit T, Wevers RA, Rutsch F, van Gennip AH: beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Hum Mol Genet. 2004 Nov 15;13(22):2793-801. Epub 2004 Sep 22.
Pubmed: 15385443
|
| Thymidine treatment |
- Leyva A, Schornagel JH, Kraal I, Wadman SK, Pinedo HM: Clinical and biochemical studies of high-dose thymidine treatment in patients with solid tumors. J Cancer Res Clin Oncol. 1984;107(3):211-6.
Pubmed: 6736109
|
| Dihydropyrimidine dehydrogenase deficiency |
- http://www.metagene.de/program/d.prg?mp=DIHYDROPYRIMIDINE%20DEHYDROGENASE%20DEFICIENCY%20(DHPD)
|
|
| Associated OMIM IDs |
- 613161
(Beta-ureidopropionase deficiency)
- 274270
(Dihydropyrimidine dehydrogenase deficiency)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021922 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
1103  |
| KEGG Compound ID |
C00178  |
| BioCyc ID |
THYMINE  |
| BiGG ID |
34151  |
| Wikipedia Link |
Thymine  |
| NuGOwiki Link |
HMDB00262  |
| Metagene Link |
HMDB00262  |
| METLIN ID |
290  |
| PubChem Compound |
1135  |
| PDB ID |
TDR  |
| ChEBI ID |
17821  |
| References |
| Synthesis Reference |
Zhang, Shi-Ying; Wu, Da-Jun; Zhang, Yan-Ping. Synthesis of thymine. Zhongguo Yiyao Gongye Zazhi (1999), 30(7), 325. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Goukassian D, Gad F, Yaar M, Eller MS, Nehal US, Gilchrest BA: Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J. 2000 Jul;14(10):1325-34.
Pubmed: 10877825
- Wassberg C, Backvall H, Diffey B, Ponten F, Berne B: Enhanced epidermal ultraviolet responses in chronically sun-exposed skin are dependent on previous sun exposure. Acta Derm Venereol. 2003;83(4):254-61.
Pubmed: 12926795
- Schilsky RL, O'Laughlin K, Ratain MJ: Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer. Cancer Res. 1986 Aug;46(8):4184-8.
Pubmed: 3731086
- Maskell R, Okubadejo OA, Payne RH, Pead L: Human infections with thymine-requiring bacteria. J Med Microbiol. 1978 Feb;11(1):33-45.
Pubmed: 621731
- Hofmann U, Schwab M, Seefried S, Marx C, Zanger UM, Eichelbaum M, Murdter TE: Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):371-80.
Pubmed: 12798197
- Ling G, Chadwick CA, Berne B, Potten CS, Ponten J, Ponten F: Epidermal p53 response and repair of thymine dimers in human skin after a single dose of ultraviolet radiation: effects of photoprotection. Acta Derm Venereol. 2001 May;81(2):81-6.
Pubmed: 11501666
- Young AR, Sheehan JM, Chadwick CA, Potten CS: Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. J Invest Dermatol. 2000 Jul;115(1):37-41.
Pubmed: 10886505
- Maskell R, Okubadejo OA, Payne RH: Thymine-requiring bacteria associated with co-trimoxazole therapy. Lancet. 1976 Apr 17;1(7964):834-5.
Pubmed: 56651
- Courdavault S, Baudouin C, Sauvaigo S, Mouret S, Candeias S, Charveron M, Favier A, Cadet J, Douki T: Unrepaired cyclobutane pyrimidine dimers do not prevent proliferation of UV-B-irradiated cultured human fibroblasts. Photochem Photobiol. 2004 Feb;79(2):145-51.
Pubmed: 15068027
- Alsarra IA, Alarifi MN: Validated liquid chromatographic determination of 5-fluorouracil in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 May 25;804(2):435-9.
Pubmed: 15081940
- van Lenthe H, van Kuilenburg AB, Ito T, Bootsma AH, van Cruchten A, Wada Y, van Gennip AH: Defects in pyrimidine degradation identified by HPLC-electrospray tandem mass spectrometry of urine specimens or urine-soaked filter paper strips. Clin Chem. 2000 Dec;46(12):1916-22.
Pubmed: 11106323
- Castro-Gago M, Camina F, Lojo S, Rodriguez-Segade S, Rodriguez-Nunez A: Concentrations of purine nucleotides and purine and pyrimidine bases in cerebrospinal fluid of neurologically healthy children. Eur J Clin Chem Clin Biochem. 1992 Nov;30(11):761-5.
Pubmed: 1489848
- Placzek M, Gaube S, Kerkmann U, Gilbertz KP, Herzinger T, Haen E, Przybilla B: Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherol. J Invest Dermatol. 2005 Feb;124(2):304-7.
Pubmed: 15675947
- Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.
Pubmed: 6656991
- Thienpont LM, Van Landuyt KG, Stockl D, Saeyens W, De Keukeleire D, De Leenheer AP: Evaluation of 2-iminoimidazolidin-4-one and thymine as respective internal standards for normal-phase and reversed-phase high-performance liquid chromatographic determination of creatinine in human serum. J Chromatogr B Biomed Appl. 1995 Mar 10;665(1):63-9.
Pubmed: 7795802
- Allgayer H, Kolb M, Stuber V, Kruis W: Effects of bile acids on base hydroxylation in a model of human colonic mucosal DNA. Cancer Detect Prev. 2002;26(1):85-9.
Pubmed: 12088208
- Rodriguez Ortner E, Hayes RB, Weissfeld J, Gelmann EP: Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology. 2006 Feb;67(2):311-5. Epub 2006 Jan 25.
Pubmed: 16442598
- Antille C, Tran C, Sorg O, Carraux P, Didierjean L, Saurat JH: Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J Invest Dermatol. 2003 Nov;121(5):1163-7.
Pubmed: 14708621
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|